INTERNATIONAL: Eli Lilly moves its Asia Pacific HQ

HONG KONG: US pharmaceutical giant Eli Lilly has moved its Asia

Pacific corporate HQ from Singapore to Hong Kong in a bid to extend its

reach into Greater China. Product PR for the drug manufacturers' range

of OTC drugs is being stepped-up in China where Eli Lilly is looking to

launch new drugs this year.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in